NextCure, Inc. (NXTC)
6.88
+0.30
(+4.56%)
USD |
NASDAQ |
Oct 15, 16:00
7.09
+0.21
(+3.05%)
After-Hours: 20:00
NextCure Net Income (Quarterly) : -14.89M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -14.89M |
| March 31, 2026 | -9.796M |
| December 31, 2025 | -9.436M |
| September 30, 2025 | -8.624M |
| June 30, 2025 | -26.81M |
| March 31, 2025 | -10.98M |
| December 31, 2024 | -11.60M |
| September 30, 2024 | -11.54M |
| June 30, 2024 | -15.40M |
| March 31, 2024 | -17.11M |
| December 31, 2023 | -14.47M |
| September 30, 2023 | -14.30M |
| June 30, 2023 | -17.86M |
| March 31, 2023 | -16.10M |
| December 31, 2022 | -17.30M |
| September 30, 2022 | -18.91M |
| June 30, 2022 | -17.92M |
| Date | Value |
|---|---|
| March 31, 2022 | -20.60M |
| December 31, 2021 | -16.94M |
| September 30, 2021 | -17.93M |
| June 30, 2021 | -17.99M |
| March 31, 2021 | -16.53M |
| December 31, 2020 | -15.46M |
| September 30, 2020 | -16.37M |
| June 30, 2020 | -14.51M |
| March 31, 2020 | 9.733M |
| December 31, 2019 | -10.93M |
| September 30, 2019 | -8.434M |
| June 30, 2019 | -8.221M |
| March 31, 2019 | -6.155M |
| September 30, 2018 | -5.71M |
| June 30, 2018 | -5.231M |
| March 31, 2018 | -4.996M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
| Sarepta Therapeutics, Inc. | -4.89M |
| Anixa Biosciences, Inc. | -2.625M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 14.89M |
| EPS Diluted (Quarterly) | -2.805 |
| Enterprise Value | 12.19M |
| Earnings Yield | -153.9% |
| Normalized Earnings Yield | -144.18 |